4//SEC Filing
BROWN JAMES F 4
Accession 0001628280-22-000415
CIK 0001358403other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 9:49 AM ET
Size
6.9 KB
Accession
0001628280-22-000415
Insider Transaction Report
Form 4
BROWN JAMES F
Director
Transactions
- Exercise/Conversion
Common Stock
2022-01-04+28,384→ 28,384 total - Exercise/Conversion
Restricted Stock Units
2022-01-04−28,384→ 0 total→ Common Stock (28,384 underlying)
Footnotes (2)
- [F1]Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer common stock.
- [F2]The RSUs vest in full upon the one year anniversary of grant date on January 4, 2021.
Documents
Issuer
BELLICUM PHARMACEUTICALS, INC
CIK 0001358403
Entity typeother
Related Parties
1- filerCIK 0001624379
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 9:49 AM ET
- Size
- 6.9 KB